Učitavanje...

DDIS-25. PENTAMIDINE; A NEW CHEMOTHERAPY TARGETING ON GLIOMA STEM LIKE CELLS

INTRODUCTION: Glioblastoma (GBM) is the most common primary malignant brain tumors. Despite aggressive therapies, median overall survival of patients who suffered from GBM is only 18 months. Furthermore, there is no effective therapy for glioma stem cells (GSCs), which act as forming tumors. Herein,...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Neuro Oncol
Glavni autori: Tamai, Sho, Jiapaer, Shabierjiang, Zhang, Guangtao, Zhang, Jiakang, Wang, Yi, Sabit, Hemragul, Tanaka, Shingo, Kinoshita, Masashi, Hirao, Atsushi, Nakada, Mitsutoshi
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2019
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847863/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.276
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!